CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 100.0%

Compliant submissions 2

Incompliant submissions 0

Total trials 2

My Organizations' Clinical Trials

Showing 1025 of 2003 entries

View as:

Antimalarial Pharmacology in Children and Pregnant Women in Uganda

Phase: N/A Priority: Normal

NCT ID: NCT01717885 Org: User:

Start: 08/31/12 End: 09/30/16 Due: 09/30/17

Pharmacogenomics in Autism Treatment

Phase: N/A Priority: Normal

NCT ID: NCT00584701 Org: User:

Start: 01/31/08 End: 05/31/09 Due: 05/31/10

Valproic Acid (Depakote ER) in Patients With Advanced Thyroid Cancer

Phase: N/A Priority: Normal

NCT ID: NCT00525135 Org: User:

Start: 08/31/07 End: 03/31/09 Due: 03/31/10

Feeding During Ibuprofen or Indomethacin Treatment of Preterm Infants

Phase: N/A Priority: Normal

NCT ID: NCT00728117 Org: User:

Start: 07/31/08 End: 09/30/12 Due: 09/30/13

Trial of Methyl B12 on Behavioral and Metabolic Measures in Children With Autism

Phase: N/A Priority: Normal

NCT ID: NCT01039792 Org: User:

Start: 01/31/10 End: 11/30/13 Due: 11/30/14

Attachment and Biobehavioral Catch-up for Depression

Phase: N/A Priority: Normal

NCT ID: NCT04050202 Org: User:

Start: 08/01/20 End: 09/30/22 Due: 09/30/23

Phase I Dose Finding and Proof-of-concept Study of Panobinostat With Standard Dose Cytarabine and Daunorubicin for Untreated Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome

Phase: N/A Priority: Normal

NCT ID: NCT01463046 Org: User:

Start: 01/31/12 End: 12/31/18 Due: 12/31/19

Inflammatory Challenge and Fear

Phase: N/A Priority: Normal

NCT ID: NCT06630884 Org: User:

Start: 03/28/25 End: 11/30/28 Due: 11/30/29

Combined Hormonal Contraceptive Use in High Risk Women: A Longitudinal Study

Phase: N/A Priority: Normal

NCT ID: NCT00361400 Org: User:

Start: 08/31/05 End: 09/30/08 Due: 09/30/09

TSA Exercise Prehabilitation in Older Adults

Phase: N/A Priority: Normal

NCT ID: NCT03212300 Org: User:

Start: 09/28/18 End: 08/12/20 Due: 08/12/21

Unrelated Stem Cell Transplantation for Adults With Hematopoietic Disorders

Phase: N/A Priority: Normal

NCT ID: NCT00511537 Org: User:

Start: 01/31/99 End: 06/30/09 Due: 06/30/10

Cognitive, Emotional, and Neural Responses to Acute Inflammation

Phase: N/A Priority: Normal

NCT ID: NCT03294564 Org: User:

Start: 01/01/18 End: 12/30/18 Due: 12/30/19

Effectiveness of Using Reduced Nicotine Cigarettes in Men and Women Smokers to Combat Nicotine Addiction

Phase: N/A Priority: Normal

NCT ID: NCT00264342 Org: User:

Start: 07/31/05 End: 07/31/10 Due: 07/31/11

buRst-supprESsion TO Stop Refractory Status Epilepticus Post-cardiac Arrest

Phase: N/A Priority: Normal

NCT ID: NCT05851391 Org: User:

Start: 08/07/23 End: 04/30/27 Due: 04/30/28

UCN-01 in Treating Patients With Advanced or Metastatic Kidney Cancer

Phase: N/A Priority: Normal

NCT ID: NCT00030888 Org: User:

Start: 12/31/02 End: - Due: -

Customized Registry Tool for Tracking Adherence to Clinical Guidelines for Head and Neck Cancers

Phase: N/A Priority: Normal

NCT ID: NCT03546322 Org: User:

Start: 06/01/18 End: 03/30/22 Due: 03/30/23

Diuretics, Hypertension, and Arrhythmias Clinical Trial

Phase: N/A Priority: Normal

NCT ID: NCT00000525 Org: User:

Start: 07/31/86 End: - Due: -

T1DM Immunotherapy Using CD4+CD127lo/-CD25+ Polyclonal Tregs

Phase: N/A Priority: Normal

NCT ID: NCT01210664 Org: User:

Start: 11/30/10 End: 01/31/17 Due: 01/31/18

Modifiers of Disease Severity in Cerebral Cavernous Malformations

Phase: N/A Priority: Normal

NCT ID: NCT01764529 Org: User:

Start: 04/27/10 End: 06/30/25 Due: 06/30/26

An Educational and Supportive Counseling Program for Increasing Antiretroviral Use and Adherence in People With HIV

Phase: N/A Priority: Normal

NCT ID: NCT00611429 Org: User:

Start: 05/31/08 End: 04/30/14 Due: 04/30/15

SKY Breath Intervention

Phase: N/A Priority: Normal

NCT ID: NCT05388110 Org: User:

Start: 04/22/22 End: 12/31/28 Due: 12/31/29

The Outreach and Prevention at ALcohol Venues in East Africa Study (OPAL-East Africa- Aim 2) (OPAL-Aim 2)

Phase: N/A Priority: Normal

NCT ID: NCT06036238 Org: User:

Start: 05/17/24 End: 06/30/27 Due: 06/30/28

Outpatient Recovery From Acute Kidney Injury Requiring Dialysis

Phase: N/A Priority: Normal

NCT ID: NCT05158153 Org: User:

Start: 10/18/21 End: 04/19/22 Due: 04/19/23

A Pilot Trial to Test the Feasibility of Utilizing Home Blood Pressure Monitoring to Optimize the Administration of Midodrine Among Decompensated Cirrhosis Patients

Phase: N/A Priority: Normal

NCT ID: NCT05928624 Org: User:

Start: 09/22/23 End: 07/01/24 Due: 07/01/25

Studying the Modification of Attention Bias Remotely After Trauma

Phase: N/A Priority: Normal

NCT ID: NCT04888169 Org: User:

Start: 04/20/23 End: 06/30/25 Due: 06/30/26

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Antimalarial Pharmacology in Children and Pregnant Women in Uganda	NCT01717885	University of California, San Francisco	user2@example.com	None	2012-08-31	2016-09-30	2017-09-30	-	-	2025-07-14
Pharmacogenomics in Autism Treatment	NCT00584701	University of California, San Francisco	user2@example.com	None	2008-01-31	2009-05-31	2010-05-31	-	-	2025-07-14
Valproic Acid (Depakote ER) in Patients With Advanced Thyroid Cancer	NCT00525135	University of California, San Francisco	user2@example.com	None	2007-08-31	2009-03-31	2010-03-31	-	-	2025-07-14
Feeding During Ibuprofen or Indomethacin Treatment of Preterm Infants	NCT00728117	University of California, San Francisco	user2@example.com	None	2008-07-31	2012-09-30	2013-09-30	-	-	2025-07-14
Trial of Methyl B12 on Behavioral and Metabolic Measures in Children With Autism	NCT01039792	University of California, San Francisco	user2@example.com	None	2010-01-31	2013-11-30	2014-11-30	-	-	2025-07-14
Attachment and Biobehavioral Catch-up for Depression	NCT04050202	University of California, San Francisco	user2@example.com	None	2020-08-01	2022-09-30	2023-09-30	-	-	2025-07-14
Phase I Dose Finding and Proof-of-concept Study of Panobinostat With Standard Dose Cytarabine and Daunorubicin for Untreated Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome	NCT01463046	University of California, San Francisco	user2@example.com	None	2012-01-31	2018-12-31	2019-12-31	-	-	2025-07-14
Inflammatory Challenge and Fear	NCT06630884	University of California, San Francisco	user2@example.com	None	2025-03-28	2028-11-30	2029-11-30	-	-	2025-07-14
Combined Hormonal Contraceptive Use in High Risk Women: A Longitudinal Study	NCT00361400	University of California, San Francisco	user2@example.com	None	2005-08-31	2008-09-30	2009-09-30	-	-	2025-07-14
TSA Exercise Prehabilitation in Older Adults	NCT03212300	University of California, San Francisco	user2@example.com	None	2018-09-28	2020-08-12	2021-08-12	-	-	2025-07-14
Unrelated Stem Cell Transplantation for Adults With Hematopoietic Disorders	NCT00511537	University of California, San Francisco	user2@example.com	None	1999-01-31	2009-06-30	2010-06-30	-	-	2025-07-14
Cognitive, Emotional, and Neural Responses to Acute Inflammation	NCT03294564	University of California, San Francisco	user2@example.com	None	2018-01-01	2018-12-30	2019-12-30	-	-	2025-07-14
Effectiveness of Using Reduced Nicotine Cigarettes in Men and Women Smokers to Combat Nicotine Addiction	NCT00264342	University of California, San Francisco	user2@example.com	None	2005-07-31	2010-07-31	2011-07-31	-	-	2025-07-14
buRst-supprESsion TO Stop Refractory Status Epilepticus Post-cardiac Arrest	NCT05851391	University of California, San Francisco	user2@example.com	None	2023-08-07	2027-04-30	2028-04-30	-	-	2025-07-14
UCN-01 in Treating Patients With Advanced or Metastatic Kidney Cancer	NCT00030888	University of California, San Francisco	user2@example.com	None	2002-12-31	-	-	-	-	2025-07-14
Customized Registry Tool for Tracking Adherence to Clinical Guidelines for Head and Neck Cancers	NCT03546322	University of California, San Francisco	user2@example.com	None	2018-06-01	2022-03-30	2023-03-30	-	-	2025-07-14
Diuretics, Hypertension, and Arrhythmias Clinical Trial	NCT00000525	University of California, San Francisco	user6@example.com	Compliant	1986-07-31	-	-	2025-07-01	-	2025-07-14
T1DM Immunotherapy Using CD4+CD127lo/-CD25+ Polyclonal Tregs	NCT01210664	University of California, San Francisco	user2@example.com	None	2010-11-30	2017-01-31	2018-01-31	-	-	2025-07-14
Modifiers of Disease Severity in Cerebral Cavernous Malformations	NCT01764529	University of California, San Francisco	user2@example.com	None	2010-04-27	2025-06-30	2026-06-30	-	-	2025-07-14
An Educational and Supportive Counseling Program for Increasing Antiretroviral Use and Adherence in People With HIV	NCT00611429	University of California, San Francisco	user2@example.com	None	2008-05-31	2014-04-30	2015-04-30	-	-	2025-07-14
SKY Breath Intervention	NCT05388110	University of California, San Francisco	user2@example.com	None	2022-04-22	2028-12-31	2029-12-31	-	-	2025-07-14
The Outreach and Prevention at ALcohol Venues in East Africa Study (OPAL-East Africa- Aim 2) (OPAL-Aim 2)	NCT06036238	University of California, San Francisco	user2@example.com	None	2024-05-17	2027-06-30	2028-06-30	-	-	2025-07-14
Outpatient Recovery From Acute Kidney Injury Requiring Dialysis	NCT05158153	University of California, San Francisco	user2@example.com	None	2021-10-18	2022-04-19	2023-04-19	-	-	2025-07-14
A Pilot Trial to Test the Feasibility of Utilizing Home Blood Pressure Monitoring to Optimize the Administration of Midodrine Among Decompensated Cirrhosis Patients	NCT05928624	University of California, San Francisco	user2@example.com	None	2023-09-22	2024-07-01	2025-07-01	-	-	2025-07-14
Studying the Modification of Attention Bias Remotely After Trauma	NCT04888169	University of California, San Francisco	user2@example.com	None	2023-04-20	2025-06-30	2026-06-30	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance